Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H21F7N4O3 |
Molecular Weight | 534.4267 |
Optical Activity | ( + ) |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@@H](O[C@H]1OCCN(CC2=NC(=O)NN2)[C@H]1C3=CC=C(F)C=C3)C4=CC(=CC(=C4)C(F)(F)F)C(F)(F)F
InChI
InChIKey=ATALOFNDEOCMKK-OITMNORJSA-N
InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1
Molecular Formula | C23H21F7N4O3 |
Molecular Weight | 534.4267 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:37:45 UTC 2023
by
admin
on
Fri Dec 15 15:37:45 UTC 2023
|
Record UNII |
1NF15YR6UY
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-VATC |
QA04AD12
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EMEND (AUTHORIZED: POSTOPERATIVE NAUSEA AND VOMITTING)
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
NDF-RT |
N0000175786
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
EMEND (AUTHORIZED: VOMITTING)
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
LIVERTOX |
NBK548897
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
NDF-RT |
N0000010262
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
NCI_THESAURUS |
C267
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
||
|
WHO-ATC |
A04AD12
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
LL-96
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
1041904
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
N0000185506
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inducers [MoA] | ||
|
135413536
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
3490
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
N0000182141
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | Cytochrome P450 3A4 Inhibitors [MoA] | ||
|
APREPITANT
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
C49173
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
N0000185507
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | Cytochrome P450 2C9 Inducers [MoA] | ||
|
230
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
m2011
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | Merck Index | ||
|
170729-80-3
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
8050
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
DB00673
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
1NF15YR6UY
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
499361
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
CHEMBL1471
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
SUB20017
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
C114556
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
748825
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
100000089541
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
358255
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | RxNorm | ||
|
DTXSID3049047
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY | |||
|
1NF15YR6UY
Created by
admin on Fri Dec 15 15:37:45 UTC 2023 , Edited by admin on Fri Dec 15 15:37:45 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
EXCRETED UNCHANGED |
Aprepitant is eliminated primarily by metabolism; aprepitant is not renally excreted.
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
||
|
TARGET -> INHIBITOR |
|
||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MINOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY GENOTOXIC->PARENT |
Potentially genotoxic N-nitorso
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Tmax | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
|
|||